Used in cancer immunotherapy to block the PD-L1 immune checkpoint protein, helping the body's T-cells recognize and attack tumor cells. It is employed in treating various cancers, including bladder, lung, and melanoma, by restoring anti-tumor immune responses. Often used in research and clinical settings to develop therapeutic antibodies and assess PD-L1 expression in tumor tissues.